APO Research
Talk to an analyst

APO RESEARCH · REPORT

Baclofe Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Baclofe Injection Market Outlook and Growth Opportunities 2026

2 January 2026198 pages

Choose your research edition.

Industry ResearchBaclofe Injection Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Baclofe Injection Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Baclofe Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032181 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Baclofe Injection Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Baclofe Injection Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Baclofe Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Baclofe Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Baclofe Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Baclofe Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Baclofe Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Baclofe Injection market include Piramal Critical Care, Polpharma, Saol Therapeutics, Mylan Inc and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Baclofe Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Baclofe Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Baclofe Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Baclofe Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Baclofe Injection Segment by Company

Piramal Critical Care

Polpharma

Saol Therapeutics

Mylan Inc

Novartis AG

Baclofe Injection Segment by Type

0.05 mg/mL

0.5 mg/mL

1 mg/mL

2 mg/mL

Baclofe Injection Segment by Application

Hospital

Clinic

Baclofe Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Baclofe Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Baclofe Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Baclofe Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Baclofe Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Baclofe Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Baclofe Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Baclofe Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Baclofe Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Baclofe Injection industry.

Chapter 3: Detailed analysis of Baclofe Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Baclofe Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Baclofe Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Baclofe Injection Industry Trends Table 2. Baclofe Injection Industry Drivers Table 3. Baclofe Injection Industry Opportunities and Challenges Table 4. Baclofe Injection Industry Restraints Table 5. Global Baclofe Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Baclofe Injection Revenue Share by Company (2021-2026) Table 7. Global Baclofe Injection Sales Volume by Company (K L) & (2021-2026) Table 8. Global Baclofe Injection Sales Volume Share by Company (2021-2026) Table 9. Global Baclofe Injection Average Price (US$/L) of Company (2021-2026) Table 10. Global Baclofe Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Baclofe Injection Key Company Manufacturing Base & Headquarters Table 12. Global Baclofe Injection Company, Product Type & Application Table 13. Global Baclofe Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Baclofe Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 0.05 mg/mL Table 18. Significant Companies of 0.5 mg/mL Table 19. Significant Companies of 1 mg/mL Table 20. Significant Companies of 2 mg/mL Table 21. Global Baclofe Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K L) Table 22. Global Baclofe Injection Sales Volume by Type (2021-2026) & (K L) Table 23. Global Baclofe Injection Sales Volume by Type (2027-2032) & (K L) Table 24. Global Baclofe Injection Sales Volume Share by Type (2021-2026) Table 25. Global Baclofe Injection Sales Volume Share by Type (2027-2032) Table 26. Global Baclofe Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Baclofe Injection Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Baclofe Injection Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Baclofe Injection Sales Value Share by Type (2021-2026) Table 30. Global Baclofe Injection Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Hospital Table 32. Significant Companies of Clinic Table 33. Global Baclofe Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K L) Table 34. Global Baclofe Injection Sales Volume by Application (2021-2026) & (K L) Table 35. Global Baclofe Injection Sales Volume by Application (2027-2032) & (K L) Table 36. Global Baclofe Injection Sales Volume Share by Application (2021-2026) Table 37. Global Baclofe Injection Sales Volume Share by Application (2027-2032) Table 38. Global Baclofe Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Baclofe Injection Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Baclofe Injection Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Baclofe Injection Sales Value Share by Application (2021-2026) Table 42. Global Baclofe Injection Sales Value Share by Application (2027-2032) Table 43. Global Baclofe Injection Sales by Region: 2021 VS 2025 VS 2032 (K L) Table 44. Global Baclofe Injection Sales by Region (2021-2026) & (K L) Table 45. Global Baclofe Injection Sales Market Share by Region (2021-2026) Table 46. Global Baclofe Injection Sales by Region (2027-2032) & (K L) Table 47. Global Baclofe Injection Sales Market Share by Region (2027-2032) Table 48. Global Baclofe Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Baclofe Injection Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Baclofe Injection Sales Value Share by Region (2021-2026) Table 51. Global Baclofe Injection Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Baclofe Injection Sales Value Share by Region (2027-2032) Table 53. Global Baclofe Injection Market Average Price (US$/L) by Region (2021-2026) Table 54. Global Baclofe Injection Market Average Price (US$/L) by Region (2027-2032) Table 55. Global Baclofe Injection Sales by Country: 2021 VS 2025 VS 2032 (K L) Table 56. Global Baclofe Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Baclofe Injection Sales by Country (2021-2026) & (K L) Table 58. Global Baclofe Injection Sales Market Share by Country (2021-2026) Table 59. Global Baclofe Injection Sales by Country (2027-2032) & (K L) Table 60. Global Baclofe Injection Sales Market Share by Country (2027-2032) Table 61. Global Baclofe Injection Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Baclofe Injection Sales Value Market Share by Country (2021-2026) Table 63. Global Baclofe Injection Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Baclofe Injection Sales Value Market Share by Country (2027-2032) Table 65. Piramal Critical Care Company Information Table 66. Piramal Critical Care Business Overview Table 67. Piramal Critical Care Baclofe Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 68. Piramal Critical Care Baclofe Injection Product Portfolio Table 69. Piramal Critical Care Recent Development Table 70. Polpharma Company Information Table 71. Polpharma Business Overview Table 72. Polpharma Baclofe Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 73. Polpharma Baclofe Injection Product Portfolio Table 74. Polpharma Recent Development Table 75. Saol Therapeutics Company Information Table 76. Saol Therapeutics Business Overview Table 77. Saol Therapeutics Baclofe Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 78. Saol Therapeutics Baclofe Injection Product Portfolio Table 79. Saol Therapeutics Recent Development Table 80. Mylan Inc Company Information Table 81. Mylan Inc Business Overview Table 82. Mylan Inc Baclofe Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 83. Mylan Inc Baclofe Injection Product Portfolio Table 84. Mylan Inc Recent Development Table 85. Novartis AG Company Information Table 86. Novartis AG Business Overview Table 87. Novartis AG Baclofe Injection Sales (K L), Value (US$ Million), Price (US$/L) and Gross Margin (2021-2026) Table 88. Novartis AG Baclofe Injection Product Portfolio Table 89. Novartis AG Recent Development Table 90. Key Raw Materials Table 91. Raw Materials Key Suppliers Table 92. Baclofe Injection Distributors List Table 93. Baclofe Injection Customers List Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Baclofe Injection Product Image Figure 2. Global Baclofe Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Baclofe Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Baclofe Injection Sales (2021-2032) & (K L) Figure 5. Global Baclofe Injection Sales Average Price (US$/L) & (2021-2032) Figure 6. Global Baclofe Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 0.05 mg/mL Image Figure 10. 0.5 mg/mL Image Figure 11. 1 mg/mL Image Figure 12. 2 mg/mL Image Figure 13. Global Baclofe Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K L) Figure 14. Global Baclofe Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Baclofe Injection Sales Volume Share by Type (2021-2032) Figure 16. Global Baclofe Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Baclofe Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Baclofe Injection Sales Value Share by Type (2021-2032) Figure 19. Hospital Image Figure 20. Clinic Image Figure 21. Global Baclofe Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K L) Figure 22. Global Baclofe Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Baclofe Injection Sales Volume Share by Application (2021-2032) Figure 24. Global Baclofe Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Baclofe Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Baclofe Injection Sales Value Share by Application (2021-2032) Figure 27. Global Baclofe Injection Sales by Region: 2021 VS 2025 VS 2032 (K L) Figure 28. Global Baclofe Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Baclofe Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Baclofe Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Baclofe Injection Sales Value (2021-2032) & (US$ Million) Figure 32. North America Baclofe Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Baclofe Injection Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Baclofe Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Baclofe Injection Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Baclofe Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Baclofe Injection Sales Value (2021-2032) & (US$ Million) Figure 38. South America Baclofe Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Baclofe Injection Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Baclofe Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Baclofe Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Baclofe Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Baclofe Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Baclofe Injection Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Baclofe Injection Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • 0.05 mg/mL
  • 0.5 mg/mL
  • 1 mg/mL
  • 2 mg/mL
Applications
  • Hospital
  • Clinic
Companies covered
  • Piramal Critical Care
  • Polpharma
  • Saol Therapeutics
  • Mylan Inc
  • Novartis AG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Baclofe Injection Sales Value (2021-2032)
  4. 1.2.2 Global Baclofe Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Baclofe Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Baclofe Injection Market Dynamics
  1. 2.1 Baclofe Injection Industry Trends
  2. 2.2 Baclofe Injection Industry Drivers
  3. 2.3 Baclofe Injection Industry Opportunities and Challenges
  4. 2.4 Baclofe Injection Industry Restraints
3 Baclofe Injection Market by Company
  1. 3.1 Global Baclofe Injection Company Revenue Ranking in 2025
  2. 3.2 Global Baclofe Injection Revenue by Company (2021-2026)
  3. 3.3 Global Baclofe Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Baclofe Injection Average Price by Company (2021-2026)
  5. 3.5 Global Baclofe Injection Company Ranking (2024-2026)
  6. 3.6 Global Baclofe Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Baclofe Injection Company Product Type and Application
  8. 3.8 Global Baclofe Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Baclofe Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Baclofe Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Baclofe Injection Market by Type
  1. 4.1 Baclofe Injection Type Introduction
  2. 4.1.1 0.05 mg/mL
  3. 4.1.2 0.5 mg/mL
  4. 4.1.3 1 mg/mL
  5. 4.1.4 2 mg/mL
  6. 4.2 Global Baclofe Injection Sales Volume by Type
  7. 4.2.1 Global Baclofe Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Baclofe Injection Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Baclofe Injection Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Baclofe Injection Sales Value by Type
  11. 4.3.1 Global Baclofe Injection Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Baclofe Injection Sales Value by Type (2021-2032)
  13. 4.3.3 Global Baclofe Injection Sales Value Share by Type (2021-2032)
5 Baclofe Injection Market by Application
  1. 5.1 Baclofe Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.2 Global Baclofe Injection Sales Volume by Application
  5. 5.2.1 Global Baclofe Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Baclofe Injection Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Baclofe Injection Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Baclofe Injection Sales Value by Application
  9. 5.3.1 Global Baclofe Injection Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Baclofe Injection Sales Value by Application (2021-2032)
  11. 5.3.3 Global Baclofe Injection Sales Value Share by Application (2021-2032)
6 Baclofe Injection Regional Sales and Value Analysis
  1. 6.1 Global Baclofe Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Baclofe Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Baclofe Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Baclofe Injection Sales by Region (2027-2032)
  5. 6.3 Global Baclofe Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Baclofe Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Baclofe Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Baclofe Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Baclofe Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Baclofe Injection Sales Value (2021-2032)
  12. 6.6.2 North America Baclofe Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Baclofe Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Baclofe Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Baclofe Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Baclofe Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Baclofe Injection Sales Value (2021-2032)
  21. 6.9.2 South America Baclofe Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Baclofe Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Baclofe Injection Sales Value Share by Country, 2025 VS 2032
7 Baclofe Injection Country-level Sales and Value Analysis
  1. 7.1 Global Baclofe Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Baclofe Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Baclofe Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Baclofe Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Baclofe Injection Sales by Country (2027-2032)
  6. 7.4 Global Baclofe Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Baclofe Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Baclofe Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Baclofe Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Baclofe Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Baclofe Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Baclofe Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Baclofe Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Baclofe Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Baclofe Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Baclofe Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Baclofe Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Baclofe Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Baclofe Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Baclofe Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Baclofe Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Baclofe Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Baclofe Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Baclofe Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Baclofe Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Baclofe Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Baclofe Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Baclofe Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Baclofe Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Baclofe Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Baclofe Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Baclofe Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Baclofe Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Baclofe Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Baclofe Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Baclofe Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Baclofe Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Baclofe Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Baclofe Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Piramal Critical Care
  2. 8.1.1 Piramal Critical Care Company Information
  3. 8.1.2 Piramal Critical Care Business Overview
  4. 8.1.3 Piramal Critical Care Baclofe Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Piramal Critical Care Baclofe Injection Product Portfolio
  6. 8.1.5 Piramal Critical Care Recent Developments
  7. 8.2 Polpharma
  8. 8.2.1 Polpharma Company Information
  9. 8.2.2 Polpharma Business Overview
  10. 8.2.3 Polpharma Baclofe Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Polpharma Baclofe Injection Product Portfolio
  12. 8.2.5 Polpharma Recent Developments
  13. 8.3 Saol Therapeutics
  14. 8.3.1 Saol Therapeutics Company Information
  15. 8.3.2 Saol Therapeutics Business Overview
  16. 8.3.3 Saol Therapeutics Baclofe Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Saol Therapeutics Baclofe Injection Product Portfolio
  18. 8.3.5 Saol Therapeutics Recent Developments
  19. 8.4 Mylan Inc
  20. 8.4.1 Mylan Inc Company Information
  21. 8.4.2 Mylan Inc Business Overview
  22. 8.4.3 Mylan Inc Baclofe Injection Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Inc Baclofe Injection Product Portfolio
  24. 8.4.5 Mylan Inc Recent Developments
  25. 8.5 Novartis AG
  26. 8.5.1 Novartis AG Company Information
  27. 8.5.2 Novartis AG Business Overview
  28. 8.5.3 Novartis AG Baclofe Injection Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Novartis AG Baclofe Injection Product Portfolio
  30. 8.5.5 Novartis AG Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Baclofe Injection Value Chain Analysis
  2. 9.1.1 Baclofe Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Baclofe Injection Sales Mode & Process
  6. 9.2 Baclofe Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Baclofe Injection Distributors
  9. 9.2.3 Baclofe Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst